Nestlé commences tender offer for Aimmune Therapeutics, Inc.

Société des Produits Nestlé S.A. (“Nestlé”) announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. (“Purchaser”), is commencing today a cash tender offer to purchase all of the outstanding shares of common stock of Aimmune Therapeutics, Inc. (Nasdaq: AIMT) (“Aimmune”) today for a price of USD 34.50 per share, net to the seller in cash, without interest and subject to any withholding taxes (the “Offer”). The Offer is being made upon the terms and subject to the conditions set fort…

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=263968


Source: WebWire
Nestlé commences tender offer for Aimmune Therapeutics, Inc.